TSE:L

Loblaw Companies Ltd (L.TO)

62.80
+1.18 (1.91%)
as of Jun 3, 2026, 8:00:00 pm Market Open.
321 watching
0
Investor Insights
star iconJun 3, 2026, 12:00 am

This summary was created by AI, based on 15 opinions in the last 12 months.

Loblaw Companies Ltd is the largest food and drug retailer in Canada, benefiting from its dominant market position, especially through strong private labels like No Name and the successful acquisition of Shoppers Drug Mart (SDM). The company has shown resilience amid inflation and rising costs, which have led to an increase in food prices, yet its focus on discount banners is resonating well with consumers seeking value. Analysts believe there's strong growth potential, particularly due to SDM's market share in pharmaceuticals and grocery. However, some experts caution that the stock is reaching its highest valuations in years, presenting a potential issue for future growth sustainability. While the technical aspects of the stock are favorable, there are concerns regarding competition from giants like Walmart and Costco, impacting its attractiveness at this valuation level.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Overvalued
review icon
Similar
Costco, COST
TOP PICK

Defensive consumer staple going into economic slowdown. Over half of food banners are in discount, seeing increased traffic. Plus, more people are cooking at home rather than eating out. SDM has great locations, offers Loblaw products; pharmacists expanding roles, and this increases general traffic. Yield is 1.45%.

(Analysts’ price target is $135.40)
TRADE

The chart is consolidating, but has been sideways for the last two years. A trade, with support around $115 to resistance around $121. Historically, this stock rises, consolidates for a while, then breaks out.

DON'T BUY

It's not their fault that food prices are so high. The bread-fixing scandal didn't help their PR. With long lines at food banks, people need a scapegoat. He owns ATD instead. This sector will remain unpopular even if it makes money.

HOLD
Take profits?

Very few competitors, and those types of names tend to perform well long-term. Largest grocery retailer, so procures good prices and controls distribution. Shoppers Drug Mart provide lots of earnings. Loyalty programs doing well. As a consumer staple, won't participate with more cyclical names. Defensive part of your portfolio. If you're up nicely, you could take some profits.

BUY

Likes it. It's an inflation story. Some consumers are gravitating away from restaurants and back to buying their own food, so it's a volume story too. Good place to be. Trading at a reasonable 15x earnings, not overly expensive. If you think we're getting into a mild recession, which might be prolonged, this is a safe bet.

COMMENT

It has grown its profits very well despite modest revenue growth. It will be challenging for it maintain these high profits over the next couple of years. He is not buying since the near term growth is low.

RISKY

Has done very well in the last couple of years, reaching 4x book value, a level not seen in 18 years. Spectacular move, but that's it. Upside to $137. Starting to roll over. Hard to say, it's betwixt and between. Be cautious.

BUY

Defensive. Owned it a while ago, but Loblaw offers better value, the Shoppers chain, exposure to cities, and better efficiencies. Neither pays a good dividend, but Empire's chart looks attractive now for the short term. 

BUY

High quality grocery business (largest in Canada).
Excellent business fundamentals.
Volatile share price - but over the long run is a good business.
Price target of $138.
Upward trend in share price.
Consumers staples a defensive sector with lower risk.

PAST TOP PICK
(A Top Pick Jul 21/22, Up 3%)

Consumer needs, not wants, is the place to be. Mid-teens PE ratio. A compounder of 14% over the last decade. Slow and steady.

HOLD

Bought near $60, when it was being ignored. Don't buy the grocers right now, they're near the top having benefited from inflation. Nice 10% growth rate, not a bad 15.6 PE. Good story, but already reflected in the price. Lots of cheap stocks out there, pick one of those.

DON'T BUY

It is making lots of money since prices are up, even though margins have not increased. The concern is if food prices drop then they would have to increase their margins. Even though it is not cheap they are buying back stock. Too expensive to buy now but it is a defensive stock.

TOP PICK

Consumer staples are defensive as we head into a slowing economy. Their discount banners are attracting customer traffic amid inflation. She likes their private labels with 25% customer penetration and strong margins. Great locations. Have benefited from the reopening as people return to the office. Drug stores will play a growing, bigger role in healthcare (Loblaw owns Shoppers Drug Mart and is well-positioned).

(Analysts’ price target is $137.05)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Jan 31/23, Down 3.2%)Stockchase Research Editor: Michael O’Reilly

Our PAST TOP PICK with L has triggered its stop at $115.  To remain disciplined, we recommend covering the position at this time. 

WAIT

Very expensive, trading up near maximums. Be patient, let things fall to something that will give you a better rate of return.

Showing 31 to 45 of 706 entries